Arner P, Einarsson K, Backman L, Nilsell K, Lerea K M, Livingston J N
J Clin Invest. 1983 Nov;72(5):1729-36. doi: 10.1172/JCI111132.
The insulin-binding isotherms and the structural composition of human liver insulin receptors were examined by using plasma membranes that were prepared from liver biopsies of nine non-obese and 10 obese subjects undergoing elective surgery. The insulin-binding characteristics of liver membranes from non-obese subjects were quite similar to those previously described in rat liver membranes. However, when the membranes from obese subjects were compared with the non-obese group, insulin-binding activity was reduced by 50% (P less than 0.01). The reduction in obesity resulted primarily from a decrease in total receptor number, although a small decrease in receptor affinity was also observed. Insulin binding was not correlated with sex or with the fasting plasma insulin level. The insulin-binding sites of liver membranes were affinity-labeled with 125I-insulin and the cross-linking reagent, disuccinimidyl suberate. The liver membranes from both the non-obese and the obese group had heterogenous (nonreduced) insulin-binding species of 300,000, 260,000, and 150,000 mol wt, which were again comparable to the findings reported in rat liver. Sulfhydryl reduction demonstrated a major sub-unit of 125,000 and a minor component of 40,000-45,000 in both groups. These results indicate a close similarity between the hepatic insulin receptor of man and the more intensely studied rat hepatic receptor. Obesity in human subjects is associated with a loss of hepatic insulin receptors. This alteration may contribute to the insulin resistance reported in this organ as well as to obesity-mediated glucose tolerance.
采用从9名接受择期手术的非肥胖受试者和10名肥胖受试者的肝活检组织制备的质膜,检测了人肝脏胰岛素受体的胰岛素结合等温线和结构组成。非肥胖受试者肝细胞膜的胰岛素结合特性与先前在大鼠肝细胞膜中描述的非常相似。然而,当将肥胖受试者的膜与非肥胖组进行比较时,胰岛素结合活性降低了50%(P<0.01)。肥胖导致的这种降低主要是由于总受体数量减少,尽管也观察到受体亲和力略有下降。胰岛素结合与性别或空腹血浆胰岛素水平无关。肝细胞膜的胰岛素结合位点用125I-胰岛素和交联剂辛二酸二琥珀酰亚胺酯进行亲和标记。非肥胖组和肥胖组的肝细胞膜均具有分子量为300,000、260,000和150,000的异质性(非还原)胰岛素结合物种,这再次与大鼠肝脏中的研究结果相当。巯基还原显示两组均有一个主要亚基为125,000,一个次要亚基为40,000 - 45,000。这些结果表明,人类肝脏胰岛素受体与研究更为深入的大鼠肝脏受体非常相似。人类受试者的肥胖与肝脏胰岛素受体的丧失有关。这种改变可能导致该器官出现胰岛素抵抗以及肥胖介导的葡萄糖耐量异常。